GYLDEN PHARMA LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameGYLDEN PHARMA LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 09955881
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of GYLDEN PHARMA LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is GYLDEN PHARMA LIMITED located?

    Registered Office Address
    4 & 5 Dunmore Court Wootton Road
    OX13 6BH Abingdon
    Oxfordshire
    England
    Undeliverable Registered Office AddressNo

    What were the previous names of GYLDEN PHARMA LIMITED?

    Previous Company Names
    Company NameFromUntil
    EMERGEX VACCINES HOLDING LIMITEDJan 18, 2016Jan 18, 2016

    What are the latest accounts for GYLDEN PHARMA LIMITED?

    OverdueYes
    Next Accounts
    Next Accounts Period End OnMar 31, 2024
    Next Accounts Due OnMar 31, 2025
    Last Accounts
    Last Accounts Made Up ToMar 31, 2023

    What is the status of the latest confirmation statement for GYLDEN PHARMA LIMITED?

    Last Confirmation Statement Made Up ToAug 07, 2025
    Next Confirmation Statement DueAug 21, 2025
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToAug 07, 2024
    OverdueNo

    What are the latest filings for GYLDEN PHARMA LIMITED?

    Filings
    DateDescriptionDocumentType

    Resolutions

    Resolutions
    2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    RES11
    incorporation

    Resolution of adoption of Articles of Association

    RES01
    capital

    Resolution of allotment of securities

    RES10

    Memorandum and Articles of Association

    58 pagesMA

    Memorandum and Articles of Association

    58 pagesMA

    Memorandum and Articles of Association

    58 pagesMA

    Statement of capital following an allotment of shares on Dec 18, 2024

    • Capital: GBP 41.061466
    4 pagesSH01

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    RES10

    Statement of capital following an allotment of shares on Dec 12, 2024

    • Capital: GBP 40.927678
    4 pagesSH01

    Memorandum and Articles of Association

    58 pagesMA

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Certificate of change of name

    Company name changed emergex vaccines holding LIMITED\certificate issued on 16/10/24
    3 pagesCERTNM
    Associated Filings
    CategoryDateDescriptionType
    change-of-nameOct 16, 2024

    Change of name by resolution

    NM01
    Resolutions
    CategoryDateDescriptionType
    change-of-name

    Change company name resolution on Oct 10, 2024

    RES15

    Statement of capital following an allotment of shares on Oct 03, 2024

    • Capital: GBP 40.869678
    4 pagesSH01

    Termination of appointment of Michael Derek Vaughn Rake as a director on Sep 03, 2024

    1 pagesTM01

    Confirmation statement made on Aug 07, 2024 with updates

    16 pagesCS01

    Director's details changed for Mr Sergio Pagani on Jul 12, 2024

    2 pagesCH01

    Statement of capital following an allotment of shares on Mar 28, 2024

    • Capital: GBP 40.749678
    4 pagesSH01

    Appointment of Dr Poh Hui Chia as a director on Jan 05, 2024

    2 pagesAP01

    Termination of appointment of Xinhong Lim as a director on Jan 05, 2024

    1 pagesTM01

    Statement of capital following an allotment of shares on Nov 20, 2023

    • Capital: GBP 40.721384
    4 pagesSH01

    Appointment of Dr Ricardo De Godoi Mattos Ferreira as a director on Sep 27, 2023

    2 pagesAP01

    Group of companies' accounts made up to Mar 31, 2023

    17 pagesAA

    Statement of capital following an allotment of shares on Sep 27, 2023

    • Capital: GBP 40.721314
    4 pagesSH01

    Statement of capital following an allotment of shares on Aug 21, 2023

    • Capital: GBP 40.721238
    4 pagesSH01

    Resolutions

    Resolutions
    2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolutions

    Director ratification/ share option plan/ 08/08/2023
    RES13
    incorporation

    Resolution of adoption of Articles of Association

    RES01
    capital

    Resolution of removal of pre-emption rights

    RES11
    capital

    Resolution of allotment of securities

    RES10

    Memorandum and Articles of Association

    57 pagesMA

    Confirmation statement made on Aug 07, 2023 with updates

    15 pagesCS01

    Who are the officers of GYLDEN PHARMA LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    CHIA, Dr Poh Hui
    Tower 1
    Harbourfront Avenue,
    098632 #16-06
    Keppel Bay
    Singapore
    Director
    Tower 1
    Harbourfront Avenue,
    098632 #16-06
    Keppel Bay
    Singapore
    SingaporeSingaporeanAssociate Director318088170001
    DE GODOI MATTOS FERREIRA, Ricardo, Dr
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    BrazilBrazilianBiologist, Researcher315837090001
    JACKSON, David Clifford
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    EnglandBritishCompany Director146695910001
    MOORE-THORNICROFT, Storme Jo-Anne
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    United KingdomBritishDirector72581670003
    PAGANI, Sergio
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    United KingdomLuxembourgerDirector249181030003
    RADEMACHER, Thomas William, Professor
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    EnglandAmericanDirector72581680001
    SENG CHIN, Finian Tan, Dr
    Harbourfront Avenue
    098632 16-06 Keppel Bay Tower
    1
    Singapore
    Director
    Harbourfront Avenue
    098632 16-06 Keppel Bay Tower
    1
    Singapore
    SingaporeSingaporeanEntrepreneur262326870001
    TUFARO, Frank
    Sitio Avellana
    CA92009 Carlsbad
    3246
    United States
    Director
    Sitio Avellana
    CA92009 Carlsbad
    3246
    United States
    United StatesAmericanCompany Director299191460001
    BRADMAN, Godfrey Michael
    Berkeley Street
    W1J 8DJ London
    1
    England
    Director
    Berkeley Street
    W1J 8DJ London
    1
    England
    EnglandBritishDirector2068500003
    DONG, Yixiang
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    EnglandChineseAccountant And Scientist238610240001
    JACKSON, David Clifford
    Burges Grove
    SW13 8BG London
    7
    England
    Director
    Burges Grove
    SW13 8BG London
    7
    England
    EnglandBritishDirector146695910001
    KING, David Anthony, Sir
    Glisson Road
    CB1 2HD Cambridge
    20
    United Kingdom
    Director
    Glisson Road
    CB1 2HD Cambridge
    20
    United Kingdom
    EnglandBritishDirector90952010001
    LIM, Xinhong, Dr
    3rd St
    San Francisco
    95
    California, 94103
    United States
    Director
    3rd St
    San Francisco
    95
    California, 94103
    United States
    United StatesSingaporeanDirector277122270001
    OAKES, Herbert
    Grosvenor Street
    W1K 4QW London
    26
    England
    Director
    Grosvenor Street
    W1K 4QW London
    26
    England
    EnglandAmericanDirector195778730001
    PHILIP, Mohan, Dr
    Corleone Drive
    Sparks
    1810
    Nv
    United States
    Director
    Corleone Drive
    Sparks
    1810
    Nv
    United States
    United StatesAmericanCompany Director229757670002
    RAKE, Michael Derek Vaughn, Sir
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    EnglandBritishCompany Director304063480001
    SEDGWICK, Anthony David, Professor
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Director
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    EnglandEnglishDirector151673490001

    Who are the persons with significant control of GYLDEN PHARMA LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Professor Thomas William Rademacher
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    Apr 06, 2016
    Wootton Road
    OX13 6BH Abingdon
    4 & 5 Dunmore Court
    Oxfordshire
    England
    No
    Nationality: American
    Country of Residence: England
    Natures of Control
    • The person has the right to exercise, or actually exercises, significant influence or control over the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0